As genetic testing has become more readily available, sequencing for pathogenic gain-of-function variants in the C terminal region of the CXCR4 gene is often used to confirm a clinical suspicion of WHIM syndrome. This evidence concerns the gene CXCR4 and WHIM syndrome.